Vimarsana
Biggest News Aggregation in the World

Page 9 - Altimmune News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Altimmune. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Altimmune Today - Breaking & Trending Today

Altimmune, Inc. (NASDAQ:ALT) Shares Purchased by Sectoral Asset Management Inc. - Vimarsana News

Altimmune, Inc. (NASDAQ:ALT) Shares Purchased by Sectoral Asset Management Inc.

Sectoral Asset Management Inc. increased its position in shares of Altimmune, Inc. (NASDAQ:ALT – Get Rating) by 27.3% in the 4th quarter, Holdings Channel.com reports. The firm owned 342,500 shares of the company’s stock after acquiring an additional 73,400 shares during the quarter. Sectoral Asset Management Inc.’s holdings in Altimmune were worth $5,634,000 at the […]

Source: wkrb13.com
Short Interest in Faraday Future Intelligent Electric Inc. (NASDAQ:FFIEW) Declines By 8.8% - Vimarsana News

Short Interest in Faraday Future Intelligent Electric Inc. (NASDAQ:FFIEW) Declines By 8.8%

Landscape Capital Management L.L.C. bought a new position in shares of Altimmune, Inc. (NASDAQ:ALT – Get Rating) in the fourth quarter, according to the company in its most recent filing with the SEC. The fund bought 28,975 shares of the company’s stock, valued at approximately $477,000. Landscape Capital Management L.L.C. owned 0.06% of Altimmune as […]

Altimmune, Inc. (NASDAQ:ALT) Given Consensus Rating of "Moderate Buy" by Analysts - Vimarsana News

Altimmune, Inc. (NASDAQ:ALT) Given Consensus Rating of "Moderate Buy" by Analysts

Shares of Altimmune, Inc. (NASDAQ:ALT – Get Rating) have earned a consensus rating of “Moderate Buy” from the eight brokerages that are currently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 1 year price target […]

Brokerages Set Altimmune, Inc. (NASDAQ:ALT) Target Price at $26.00 - Vimarsana News

Brokerages Set Altimmune, Inc. (NASDAQ:ALT) Target Price at $26.00

Altimmune, Inc. (NASDAQ:ALT – Get Rating) has earned an average recommendation of “Moderate Buy” from the eight brokerages that are covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating and seven have given a buy rating to the company. The average 12 month target price among brokers […]

Source: wkrb13.com
Altimmune, Inc. (NASDAQ:ALT) Given Average Recommendation of "Moderate Buy" by Analysts - Vimarsana News

Altimmune, Inc. (NASDAQ:ALT) Given Average Recommendation of "Moderate Buy" by Analysts

Altimmune, Inc. (NASDAQ:ALT – Get Rating) has been assigned a consensus rating of “Moderate Buy” from the eight brokerages that are covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold rating and seven have issued a buy rating on the company. The average 12 month target price among brokerages […]

Source: wkrb13.com